Impaired circulating dendritic cell reconstitution identifies rejecting recipients after clinical heart transplantation independent of rejection therapy

Athanassopoulos, Petros; Vaessen, Leonard M.B.; Balk, Aggie H.M.M.; Takkenberg, Johanna J.M.; Maat, Alex P.W.M.; Weimar, Willem; Bogers, Ad J.J.C.
May 2005
European Journal of Cardio-Thoracic Surgery;May2005, Vol. 27 Issue 5, p783
Academic Journal
Abstract: Objective: Dendritic cell (DC) mediated allo-antigen presentation to host antigen specific T-lymphocytes initiates acute allograft rejection. We investigated peripheral blood DC (PBDC) incidence and DC subset reconstitution in relation to histological diagnosis of acute cellular rejection (AR) and administration of rejection therapy after clinical heart transplantation (post-HTx). Methods: Venous blood from 20 HTx recipients under standard immunosuppression was collected during serial endomyocardial biopsy (EMB) prior to administration of rejection therapy in a 9-month follow-up post-HTx. Echocardiographic assessment of allograft function during EMB was performed to distinguish clinical necessity for rejection therapy within histologically rejecting patients (R). Myeloid (mDC) and plasmacytoid (pDC) subsets identified by flow-cytometry were analysed for different ISHLT rejection grades. Circulating PBDC incidence and mDC/pDC ratio were compared sequentially between non-rejecting (NR) recipients and R patients treated (3A+) or not-treated (3A−) with rejection therapy during follow-up. Results: Eleven samples from biopsy-proven AR episodes (AR+: ISHLT≥3) were compared to 89 samples from non-rejection episodes (AR−: ISHLT grade 0, n=52; grade 1, n=29; grade 2, n=8). We observed an inverse correlation of mDCs (P<0.05) but not pDCs with increasing rejection grade. PBDC incidence and mDC/pDC ratio were low in blood samples obtained during AR (P<0.05 and P<0.01, respectively). Both PBDCs and mDC/pDC ratio decreased during each AR episode (P<0.05). Comparison of 3A+ and 3A− rejectors with NR patients after 12 weeks post-HTx revealed lower PBDC incidence (P<0.01) and mDC/pDC ratio (P<0.05) for R patients, independent of rejection therapy. Conclusions: Defective DC subset reconstitution by dendritic cell profiling identifies patients at risk for AR after 3 months post-HTx. This finding may contribute to further optimization of immunosuppressive treatment strategies after clinical heart transplantation.


Related Articles

  • Prognostic Significance of RCAS1 Expression in Relation to the Infiltration of Dendritic Cells and Lymphocytes in Patients with Esophageal Carcinoma. Shunichi Tsujitani; Hiroaki Saito; Shinichi Oka; Teruhisa Sakamoto; Shingo Kanaji; Shigeru Tatebe; Masahide Ikeguchi // Digestive Diseases & Sciences;Feb2007, Vol. 52 Issue 2, p549 

    Abstract??RCAS1 (receptor-binding cancer antigen expressed on SiSo cells) expression was determined in 107 esophageal carcinoma patients by immunohistochemical procedures and compared with tumor infiltrating lymphocyte (TIL) and dendritic cell (DC) infiltration to evaluate the effect of RCAS1 on...

  • The lymphoid chemokine CCL21 triggers LFA-1 adhesive properties on human dendritic cells. Eich, Christina; de Vries, I. Jolanda M.; Linssen, Peter C. M.; de Boer, Annemiek; Boezeman, Jan B.; Figdor, Carl G.; Cambi, Alessandra // Immunology & Cell Biology;Mar2011, Vol. 89 Issue 3, p458 

    Dendritic cells (DCs) are the most potent APCs, involved in the induction of immunity and tolerance. Recently we showed that during differentiation of human DCs from monocyte precursors, Lymphocyte function-associated antigen-1 (LFA-1)-binding capacity is lost, although integrin expression...

  • Specific localization of epidermal-type fatty acid binding protein in dendritic cells of splenic white pulp. Kitanaka, Noriko; Owada, Yuji; Abdelwahab, Soha Abdelkawi; Iwasa, Hiroo; Sakagami, Hiroyuki; Watanabe, Makoto; Spener, Friedrich; Kondo, Hisatake // Histochemistry & Cell Biology;Dec2003, Vol. 120 Issue 6, p465 

    Dendritic cells in the splenic white pulp of mice were intensely immunoreactive for epidermal-type fatty acid binding protein (E-FABP). This specific immunostaining revealed a clear difference in morphology between the dendritic cells in the periarterial lymphoid sheath (PALS) and follicular...

  • The role of dendritic cell precursors in tumour vasculogenesis. Coukos, G.; Benencia, F.; Buckanovich, R. J.; Conejo-Garcia, J. R. // British Journal of Cancer;4/11/2005, Vol. 92 Issue 7, p1182 

    In this review, we discuss the recent identification in vivo of a population of CD11c+ cells exhibiting simultaneous expression of both endothelial and dendritic cell markers, termed vascular leukocytes (VLCs). VLCs are highly represented in human ovarian carcinomas and, depending on the milieu,...

  • T-cell priming by dendriticcells in lymph nodes occurs in three distinct phases. Mempel, Thorsten R.; Henrickson, Sarah E.; von Andrian, Ulrich H. // Nature;1/8/2004, Vol. 427 Issue 6970, p154 

    Primary T-cell responses in lymph nodes (LNs) require contact-dependent information exchange between T cells and dendritic cells (DCs). Because lymphocytes continually enter and leave normal LNs, the resident lymphocyte pool is composed of non-synchronized cells with different dwell times that...

  • CD69 Modulates Sphingosine-1-Phosphate-Induced Migration of Skin Dendritic Cells. Lamana, Amalia; Martin, Pilar; de la Fuente, Hortensia; Martinez-Muñoz, Laura; Cruz-Adalia, Aranzazu; Ramirez-Huesca, Marta; Escribano, Cristina; Gollmer, Kathrin; Mellado, Mario; Stein, Jens V.; Rodriguez-Fernandez, Jose Luis; Sanchez-Madrid, Francisco; del Hoyo, Gloria Martinez // Journal of Investigative Dermatology;Jul2011, Vol. 131 Issue 7, p1503 

    In this study, we have investigated the role of CD69, an early inducible leukocyte activation receptor, in murine dendritic cell (DC) differentiation, maturation, and migration. Skin DCs and DC subsets present in mouse lymphoid organs express CD69 in response to maturation stimuli. Using a...

  • Dendritic cells: open for presentation business. Saveanu, Loredana; van Endert, Peter // Nature Immunology;Jan2005, Vol. 6 Issue 1, p7 

    The article presents news related to related to developments in the immunology field. It demonstrates that soluble antigens have full access to the perinuclear ER in dendritic cells (DCs). DCs have the unique capacity of processing soluble exogenous proteins for presentation to killer T...

  • MicroRNAs regulatory networks in myeloid lineage development and differentiation: regulators of the regulators. El Gazzar, Mohamed; McCall, Charles E // Immunology & Cell Biology;Jul2012, Vol. 90 Issue 6, p587 

    MicroRNAs (miRNAs) are abundant small molecules of ∼22 nucleotides that reprogram gene expression by targeting mRNA degradation and translation disruption. An emerging concept implicates miRNA coupling with transcription factors in myeloid-based development of dendritic cells, monocytes and...

  • Overview of Cellular Immunotherapy for Patients with Glioblastoma. Vauleon, Elodie; Avril, Tony; Collet, Brigitte; Mosser, Jean; Quillien, Veronique // Clinical & Developmental Immunology;2010, p1 

    High grade gliomas (HGG) including glioblastomas (GBM) are the most common and devastating primary brain tumours. Despite important progresses in GBM treatment that currently includes surgery combined to radio- and chemotherapy, GBM patients' prognosis remains very poor. Immunotherapy is one of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics